Apriem Advisors’s St Jude Medical STJ Stock Holding History

Apriem Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-44	Closed	-$2K	–	667
2016 Q1	$2K	Buy	+44	New	+$2.4K	﹤0.01%	538

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Apriem Advisors's STJ Position: Q2 2016 in Review

Apriem Advisors sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 44 shares — an estimated $2K sold.

Apriem Advisors first reported a position in STJ in Q1 2016 and held it in 1 quarter. The position peaked at $2K in Q1 2016. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

Apriem Advisors reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
Apriem Advisors sold 44 St Jude Medical shares in Q2 2016, an estimated $2K.
Apriem Advisors first reported a position in St Jude Medical in Q1 2016 and held it in 1 quarter.
Apriem Advisors's St Jude Medical position peaked at $2K in Q1 2016.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Apriem Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.